ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Carcinogenicity Tests

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Toxicity Tests ∟ Carcinogenicity Tests 8 coordinate concepts ∟ Acute Toxicity Tests \| ∟ Cytotoxicity Tests, Immunologic \| ∟ Inhibitory Concentration 50 \| ∟ Lethal Dose 50 \| ∟ Maximum Tolerated Dose \| ∟ Mutagenicity Tests \| ∟ No-Observed-Adverse-Effect Level \| ∟ Toxicity Tests, Chronic X
Broader terms:	Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Toxicity Tests ∟ Carcinogenicity Tests Toxicity Tests > Investigative Techniques > Medical Subject Headings (MeSH) X
Annotation:	NIM; Manual 24.5.6.2+ X
History note:	Carcinogens (1966-1988) \| Mutagenicity Tests (1981-1988)X
historyNote*:	89 X
publicMeSHNote*:	89 X
Scope note:	Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. X
activeMeSHYear*:	1995 \| 1996 \| 1997 \| 1998 \| 1999 \| 2000 \| 2001 \| 2002 \| 2003 \| 2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1988-04-23X
dateEstablished*:	1989-01-01X
dateRevised*:	1994-05-12X
recordAuthorizer*:	PLSX
recordMaintainer*:	AGSX
recordOriginator*:	EJBX
Related term:	Mutagenicity Tests X
Type:	Concept X
Coordinate terms:	Acute Toxicity Tests \| Cytotoxicity Tests, Immunologic \| Inhibitory Concentration 50 \| Lethal Dose 50 \| Maximum Tolerated Dose \| Mutagenicity Tests \| No-Observed-Adverse-Effect Level \| Toxicity Tests, Chronic X
URI:	X
Labels and equivalent concepts:	Karsinogeenisuustutkimukset (fi) Karsinogeenisuuskoe (fi, replaced) Karsinogeenisuuskokeet (fi, replaced) Karsinogeenisuustutkimus (fi, replaced) Karcinogenicitetstester (sv) Tumorigenicity Tests (en, replaced) Carcinogenic Potency Tests (en, replaced) Carcinogenesis Tests (en, replaced) Carcinogenic Activity Tests (en, replaced) Carcinogen Tests (en, replaced) X
Share:	X